This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Inventor Markus Emmler
Introduction
Markus Emmler is an innovative inventor based in Penzberg, Germany. He holds a significant patent that reflects his contributions to the field of metabolic engineering, particularly in understanding the role of carbon dioxide in cellular processes.
Latest Patents
Emmler's patent focuses on COprofile cultivation, which highlights how dissolved carbon dioxide in aqueous solutions directly influences the intracellular pH (pHi) value. By affecting important cellular processes, this innovation sheds light on the enzyme carbonic anhydrase II (CAII), which catalyzes the equilibrium of carbon dioxide in aqueous solutions. His findings suggest that the cell line stably expressing human CAII demonstrates enhanced re-alkalinization of the cytoplasm after induced carbonic acid load. This work reveals that increased carbon dioxide levels promote a quicker progression of the G0/G1 cell cycle phase in both transfected and control cell lines, showcasing the potential of CAII in metabolic engineering applications.
Career Highlights
Markus Emmler is affiliated with Hoffmann-La Roche Inc., where he has the opportunity to further advance his research and innovation in the field of metabolic engineering. His dedication to understanding the biochemical mechanisms at play has led him to achieve recognition within the scientific community.
Collaborations
Throughout his career, Markus has collaborated with talented colleagues such as Betina Da Silva Ribeiro and Alexander Jockwer. These partnerships have fostered an environment of innovation and collective progress in their research endeavors, further solidifying their contributions to the scientific domain.
Conclusion
Markus Emmler's work exemplifies the intersection of innovation and scientific inquiry. His patent on COprofile cultivation not only advances our understanding of cellular processes but also opens new avenues for research in metabolic engineering. Through collaboration and a commitment to excellence, Emmler continues to make significant strides in his field.